Safety and efficacy of combining capecitabine and temozolomide (CAPTEM) to treat advanced neuroendocrine neoplasms: A meta-analysis

Retrospective studies have suggested that capecitabine combined with temozolomide (CAPTEM) is effective for treating patients with advanced neuroendocrine neoplasms (NENs); however, the efficacy and safety of this regimen needs to be verified by high-quality evidence or results of randomized control...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Yaoheng, Zhao, Zhicheng, Wang, Ji, Lv, Wenhao, Lu, Li, Fu, Weihua, Li, Weidong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6203503/
https://www.ncbi.nlm.nih.gov/pubmed/30313101
http://dx.doi.org/10.1097/MD.0000000000012784

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6203503/
https://www.ncbi.nlm.nih.gov/pubmed/30313101
http://dx.doi.org/10.1097/MD.0000000000012784

Ejemplares similares